Drug use
Analysis of Desomorphine in Urine Using Liquid Chromatography-Tandem Mass Spectrometry
Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
Drug screening method development for paper spray coupled to a triple quadrupole mass spectrometer
Adolescent Substance Use: Latent Class and Transition Analysis
Methamphetamine and Violence in Illinois
Disproportionate Sentencing of Minority Drug Offenders in Illinois: Report on Changes in Drug Laws 1985-2002
Drug Abuse, Treatment, and Probationer Recidivism
Evaluating the Effectiveness of NORTH STAR: A Community-Based Framework to Reduce Adult Substance Misuse, Intimate-Partner Violence, Child Abuse, Suicidality, and Cumulative Risk
The Need to Rethink Harm Reduction for People Using Drugs Alone to Reduce Overdose Fatalities
The Impact of Drugs on Human Decomposition: What Insect, Scavenger, and Microbial Evidence Tells Us
Do Drug Courts Reduce the Use of Incarceration?: A Meta-Analysis
Phase II Metabolites of Drugs in Hair: A Potential Solution for Environmental Contamination
The Impact of NORTH STAR on Suicidality, Substance Problems, Intimate-Partner Violence, and Child Abuse
Evaluating the Effectiveness of NORTH STAR: A Community-Based Framework to Reduce Adult Substance Misuse, Intimate-Partner Violence, Child Abuse, Suicidality, and Cumulative Risk
Evaluation and Classification of Fentanyl Related Compounds using EC-SERS and Machine Learning
The Need to Rethink Harm Reduction for People Using Drugs Alone to Reduce Overdose Fatalities
Brief report: Synthetic cannabinoid use among military personnel
A Data-Informed Response to Emerging Drugs
The emerging drug crisis in the U.S. touches both criminal justice and public health, and experts from both fields came together at NIJ’s 2023 National Research Conference to discuss strategies and tools to fight this problem. Dr. Frances Scott, NIJ scientist and program manager, continues the conference discussion with two fellow panelists: Ciena Bayard, the Method Development and Validation Program Manager for D.C. Office of the Chief Medical Examiner, and Haley Greene, the Deputy Epidemiologist for the Central Region for the Virginia Department of Health. Read the transcript.